Tech Company Financing Transactions
Biopharmaceutical Research Company Funding Round
Biopharmaceutical Research Company closed a $20 million Series A venture capital round on 10/4/2022. Investors included Intrinsic Capital Partners, Achari Ventures and AFI Capital Partners.
Transaction Overview
Company Name
Announced On
10/4/2022
Transaction Type
Venture Equity
Amount
$20,000,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to scale up and increase product offering, conduct sponsored research, and execute on its go-to-market strategy.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
11045 Commercial Parkway
Castroville, CA 95012
USA
Castroville, CA 95012
USA
Phone
Undisclosed
Website
Email Address
Overview
BRC is a fully integrated, botanical cannabis pharmaceutical research, development and production company.Our mission is to develop federally compliant active pharmaceutical ingredients for plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere. As a fully licensed, federally compliant cannabis pharmaceutical company, we are able to conduct all botanical API activities. We will also support the Investigational New Drug (IND) applications of several researchers searching for treatments for PTSD, chronic pain and others.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
George Hodgin
Browse more venture capital transactions:
Prev: 10/4/2022: Partake Foods venture capital transaction
Next: 10/4/2022: Fero International venture capital transaction
Share this article
Where The Data Comes From
We report on every notable VC transaction. VC transactions on this site come from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs